6.595
0.68%
-0.045
After Hours:
6.595
Lifecore Biomedical Inc stock is currently priced at $6.595, with a 24-hour trading volume of 110.91K.
It has seen a -0.68% decreased in the last 24 hours and a +27.81% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $6.50 pivot point. If it approaches the $6.89 resistance level, significant changes may occur.
Previous Close:
$6.64
Open:
$6.63
24h Volume:
110.91K
Market Cap:
$201.46M
Revenue:
$135.28M
Net Income/Loss:
$-99.56M
P/E Ratio:
-1.9864
EPS:
-3.32
Net Cash Flow:
$-38.92M
1W Performance:
-1.42%
1M Performance:
+27.81%
6M Performance:
-7.11%
1Y Performance:
+56.28%
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
952 368 4300
Address
3515 Lyman Boulevard, Chaska
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
GlobeNewswire Inc.
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
GlobeNewswire Inc.
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
Zacks Investment Research
Dow Surges 350 Points; Fed Holds Rates Steady
Benzinga
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher
Benzinga
US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views
Benzinga
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Lifecore Biomedical Inc (LFCR) Revenue 2024
LFCR reported a revenue (TTM) of $135.28 million for the quarter ending May 31, 2023, a -5.80% decline year-over-year.
Lifecore Biomedical Inc (LFCR) Net Income 2024
LFCR net income (TTM) was -$99.56 million for the quarter ending May 31, 2023, a +14.61% increase year-over-year.
Lifecore Biomedical Inc (LFCR) Cash Flow 2024
LFCR recorded a free cash flow (TTM) of -$38.92 million for the quarter ending May 31, 2023, a +25.91% increase year-over-year.
Lifecore Biomedical Inc (LFCR) Earnings per Share 2024
LFCR earnings per share (TTM) was -$3.32 for the quarter ending May 31, 2023, a -0.30% decline year-over-year.
About Lifecore Biomedical Inc
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Cap:
|
Volume (24h):